Category: News Alert

News Alert

New Study Finds 340B Contract Pharmacy Growth in Affluent and White Neighborhoods, Hospitals Criticize Research

In News Alert, Research/ReportsJune 17, 2022627 Views

340B contract pharmacy grew in affluent and White neighborhoods from 2011 to 2019 but declined in impoverished, Black, and Latino neighborhoods, a study published in JAMA Health Forum found. AHA strongly criticized the study.

340B contract pharmacy grew in affluent and White neighborhoods from 2011 to 2019 but declined in impoverished, Black, and Latino neighborhoods, raising questions about “the degree to which 340B program growth serves vulnerable communities,” according to research published

…

Health Centers Ask Congress and Biden to Intervene to Protect 340B Savings from Pharma and PBM “Greed”

In News Alert, Research/Reports, Trade AssociationJune 13, 2022830 Views

Tom Mirga

An infographic NACHC released today in conjunction with a new survey of its members. The health center association wants Congress and the Biden administration to pass laws protecting centers from drug manufacturer and PBM policies that it says threaten centers' financial viability.

The National Association of Community Health Centers urged Congress and the Biden administration this afternoon to force drug companies to ship 340B drugs to contract pharmacies unconditionally and stop pharmacy benefit managers from siphoning off health centers’ 340B

…

Exelixis, Maker of Expensive Cancer Drugs, Is Latest Manufacturer to Impose 340B Contract Pharmacy Conditions

In News Alert, Pharma IndustryJune 8, 20221206 Views

Tom Mirga

California-based biopharmaceutical company Exelixis is the 17th drug manufacturer to impose conditions on 340B pricing when hospitals use contract pharmacies.

Biopharmaceutical manufacturer Exelixis yesterday became the 17^th drug maker to impose conditions on 340B pricing when hospitals use contract pharmacies.

The company, a specialty manufacturer with two high-priced drug products on the market, announced its policy in email notices

…

25 States File Joint Briefs Backing HHS and HRSA in 340B Contract Pharmacy Cases

In Federal, Judicial, News AlertMay 16, 20221580 Views

Tom Mirga

Connecticut Attorney General William Tong (D) led the coalition of states backing the federal government in 340B contract pharmacy cases before federal appeals courts.

Twenty-five states are backing the federal government in litigation before two federal appeals courts over drug manufacturers’ denials of 340B pricing when covered entities use contract pharmacies.

A bipartisan group of state attorneys general filed friend of the

…

Merck Extends its Conditions on 340B Pricing Involving Contract Pharmacies to Health Centers

In News Alert, Pharma IndustryApril 28, 20221679 Views

Tom Mirga

Merck extended its restrictions on 340B pricing involving contract pharmacies to community health centers.

Drug manufacturer Merck today extended its restrictions on 340B pricing involving contract pharmacies to community health centers. The restrictions have applied only to hospital covered entities until now.

Other grantee covered entities remain exempt “at this time,” Merck

…

HRSA Refers Boehringer Ingelheim to HHS Inspector General over its 340B Contract Pharmacy Policy

In Federal, News Alert, Pharma Industry, RegulatoryMarch 29, 20221426 Views

Tom Mirga

HRSA has referred Boehringer Ingelheim to the HHS Inspector General for possible imposition of civil monetary penalties over BI's conditions on 340B pricing when hospitals use contract pharmacies.

The U.S. Health Resources and Services Administration (HRSA) today turned the screws tighter on Boehringer Ingelheim (BI) over its “continued failure to provide the 340B price to covered entities utilizing contract pharmacies.”

HRSA told BI in a

…

Johnson & Johnson Becomes the 16th Drug Manufacturer to Restrict 340B Contract Pharmacy

In News Alert, Pharma IndustryMarch 21, 20221853 Views

Tom Mirga

Johnson & Johnson is the 16th drug manufacturer to impose conditions on 340B pricing when hospitals use contract pharmacies.

Drug manufacturer Johnson & Johnson this afternoon announced conditions on 340B sales on 29 products—including several of its top-selling drugs—when hospitals use contract pharmacies.

Please Login or Become a Paid Subscriber to

…

Exclusive: Leading Health Center Organization Calls Gilead’s New 340B Contract Pharmacy Restrictions “Unconscionable”

In News Alert, Pharma Industry, Trade AssociationMarch 21, 20221318 Views

Tom Mirga

NACHC called Gilead's 340B pricing conditions on Vosevi and three of its other hepatitis C drugs "the latest example of corporate greed from a pharmaceutical company."

The National Association of Community Health Centers (NACHC) told drug manufacturer Gilead this morning its new conditions on 340B contract pharmacy pricing on its branded hepatitis C treatments are “unconscionable,” “appalling,” “wrongheaded,” and “the latest example of corporate

…

HRSA Starts Contacting Hospitals Forced Out of 340B During Pandemic About Possible Reinstatement

In Federal, News Alert, RegulatoryMarch 18, 2022601 Views

Tom Mirga

HRSA began contacting hospitals today about possible reinstatement in 340B if their termination was due to their DSH adjustment percentage falling as a result of the hospital's COVID-19 response.

UPDATE Friday, March 18, 2022, 1:30 p.m. EDT—The U.S. Health Resources and Services Administration (HRSA) told 340B Report shortly after this story was published, “To be eligible, [a] hospital’s termination must have been as a result of actions

…

Gilead Announces 340B Contract Pharmacy Restrictions that Apply to Hospital and Grantee Entities

In News Alert, Pharma IndustryMarch 16, 20222805 Views

Tom Mirga

Gilead is requiring 340B covered entities to supply claims data for its branded hepatitis C products to be able to continue to be eligible for bill to / ship to orders for multiple contract pharmacies.

Gilead late yesterday imposed conditions on 340B pricing on its branded hepatitis C treatments when covered entities use contract pharmacies. It is the 15th manufacturer to place restrictions on its 340B contract pharmacy program.

The policy, which applies

…

News Alert

News Alert

News Alert

News Alert

News Alert

News Alert

News Alert

Please Login or Become a Paid Subscriber to

News Alert

News Alert

News Alert

Site Footer